Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

By sjmartinez • April 12, 2024

Greenstein YY, Hubel K, Froess J, Wisniewski SR, Venugopal V, Lai YH, Berger JS, Chang SY, Colovos C, Shah F, Kornblith LZ, Lawler PR, Gaddh M, Guerrero RM, Nkemdirim W, Lopes RD, Reynolds HR, Amigo JS, Wahid L, Zahra A, Goligher EC, Zarychanski R, Leifer E, Huang DT, Neal MD, Hochman JS, Cushman M, Gong MN. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life. Chest. 2024 Apr;165(4):785-799. doi: 10.1016/j.chest.2023.11.019. Epub 2023 Nov 17. PMID: 37979717.

Tags: Anticoagulation, covid-19, Heparin, Publications, Pulmonary, Critical Care & Sleep Medicine, Quality of Life

Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries

Zhou FF, Essien UR, Souza JM, Sarkisian CA, Damberg CL, Landon BE, Mafi JN. Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries. JAMA Netw[...]

Digital Health Technology Use Among Spanish Speakers in the US: A Scoping Review

Higashi RT, Thakur B, Repasky EC, Casillas A, Steitz BD, Hogan TP, Lehmann CU, Peterson ED, Navar AM, Turer RW. Digital Health Technology Use Among[...]

Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial

Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie[...]